Page 55 - Read Online

Pang et al. Mini-invasive Surg 2024;8:27 https://dx.doi.org/10.20517/2574-1225.2023.124 Page 9 of 11

Reviewed and approved the final manuscript to be published: Pang F, Guo Y, Liu TR

Availability of data and materials
Not applicable.

Financial support and sponsorship
The current study was supported by the National Science Foundation of China (grant nos. 81972896 and
81302368), the Project of State Key Laboratory (State Key Laboratory of oncology in South China, grant no.
HN2019-09), the Guangdong Province Natural Science Foundation (grant no. 2019A1515010288 and
2015A030313058) and the Scientific and Technological Project in Guangzhou (grant no. 2060206).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence
and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. DOI PubMed
2. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet 2019;394:64-80. DOI PubMed
3. Yu WM, Hussain SSM. Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South
East Asia: review. J Laryngol Otol 2009;123:1067-74. DOI PubMed
4. Tang LL, Chen YP, Chen CB, et al. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and
treatment of nasopharyngeal carcinoma. Cancer Commun 2021;41:1195-227. DOI PubMed PMC
5. Bossi P, Chan AT, Licitra L, et al; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org, EURACAN.
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol
2021;32:452-65. DOI PubMed
6. Mao YP, Tang LL, Chen L, et al. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-
modulated radiotherapy. Chin J Cancer 2016;35:103. DOI PubMed PMC
7. Yi JL, Gao L, Huang X, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single
institution. Int J Radiat Oncol Biol Phys 2006;65:161-8. DOI PubMed
8. Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 2019;79:101890.
DOI PubMed
9. Liu TR, Chen FJ, Zhang GP, Yang AK. Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas.
Curr Opin Otolaryngol Head Neck Surg 2011;19:87-91. DOI PubMed
10. Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I
nasopharyngeal carcinoma. Cancer Commun 2019;39:75. DOI PubMed PMC
11. Badoual C. Update from the 5th edition of the World Health Organization classification of head and neck tumors: oropharynx and
nasopharynx. Head Neck Pathol 2022;16:19-30. DOI PubMed PMC
12. Wang HY, Chang YL, To KF, et al. A new prognostic histopathologic classification of nasopharyngeal carcinoma. Chin J Cancer
2016;35:41. DOI PubMed PMC
13. Shin DH, Mark EJ, Suen HC, Grillo HC. Pathologic staging of papillary carcinoma of the thyroid with airway invasion based on the
anatomic manner of extension to the trachea: a clinicopathologic study based on 22 patients who underwent thyroidectomy and airway
resection. Hum Pathol 1993;24:866-70. DOI PubMed
14. Dai Q, Shi YX, Zhang HK, et al. Salvage endoscopic surgery for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a
prospective, observational, single-arm clinical study. Rhinology 2023;61:61-70. DOI PubMed
15. Lee AW, Ng WT, Pan JJ, et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for